175 related articles for article (PubMed ID: 29797496)
41. Molecular interaction fingerprint approaches for GPCR drug discovery.
Vass M; Kooistra AJ; Ritschel T; Leurs R; de Esch IJ; de Graaf C
Curr Opin Pharmacol; 2016 Oct; 30():59-68. PubMed ID: 27479316
[TBL] [Abstract][Full Text] [Related]
42. Docking and Virtual Screening in Drug Discovery.
Kontoyianni M
Methods Mol Biol; 2017; 1647():255-266. PubMed ID: 28809009
[TBL] [Abstract][Full Text] [Related]
43. A Structure-Based Drug Discovery Paradigm.
Batool M; Ahmad B; Choi S
Int J Mol Sci; 2019 Jun; 20(11):. PubMed ID: 31174387
[TBL] [Abstract][Full Text] [Related]
44. Prediction of drug-target interaction by label propagation with mutual interaction information derived from heterogeneous network.
Yan XY; Zhang SW; Zhang SY
Mol Biosyst; 2016 Feb; 12(2):520-31. PubMed ID: 26675534
[TBL] [Abstract][Full Text] [Related]
45. Omics Data Integration and Analysis for Systems Pharmacology.
Lim H; Xie L
Methods Mol Biol; 2019; 1939():199-214. PubMed ID: 30848463
[TBL] [Abstract][Full Text] [Related]
46. Modeling Polypharmacological Profiles by Affinity Fingerprinting.
Peragovics A; Simon Z; Malnasi-Csizmadia A; Bender A
Curr Pharm Des; 2016; 22(46):6885-6894. PubMed ID: 27587199
[TBL] [Abstract][Full Text] [Related]
47. [Prediction of network drug target based on improved model of bipartite graph valuation].
Liu X; Lu P; Zuo X; Chen J; Yang H; Yang Y; Gao Y
Zhongguo Zhong Yao Za Zhi; 2012 Jan; 37(2):125-9. PubMed ID: 22737836
[TBL] [Abstract][Full Text] [Related]
48. A Review of Computational Methods for Predicting Drug Targets.
Huang G; Yan F; Tan D
Curr Protein Pept Sci; 2018; 19(6):562-572. PubMed ID: 27842478
[TBL] [Abstract][Full Text] [Related]
49. Improved pose and affinity predictions using different protocols tailored on the basis of data availability.
Prathipati P; Nagao C; Ahmad S; Mizuguchi K
J Comput Aided Mol Des; 2016 Sep; 30(9):817-828. PubMed ID: 27714493
[TBL] [Abstract][Full Text] [Related]
50. Network pharmacology-based analysis of Chinese herbal Naodesheng formula for application to Alzheimer's disease.
Pang XC; Kang D; Fang JS; Zhao Y; Xu LJ; Lian WW; Liu AL; DU GH
Chin J Nat Med; 2018 Jan; 16(1):53-62. PubMed ID: 29425590
[TBL] [Abstract][Full Text] [Related]
51. Modeling compound-target interaction network of traditional Chinese medicines for type II diabetes mellitus: insight for polypharmacology and drug design.
Tian S; Li Y; Li D; Xu X; Wang J; Zhang Q; Hou T
J Chem Inf Model; 2013 Jul; 53(7):1787-803. PubMed ID: 23768230
[TBL] [Abstract][Full Text] [Related]
52. Large-Scale Off-Target Identification Using Fast and Accurate Dual Regularized One-Class Collaborative Filtering and Its Application to Drug Repurposing.
Lim H; Poleksic A; Yao Y; Tong H; He D; Zhuang L; Meng P; Xie L
PLoS Comput Biol; 2016 Oct; 12(10):e1005135. PubMed ID: 27716836
[TBL] [Abstract][Full Text] [Related]
53. Structure-Based Virtual Screening.
Li Q; Shah S
Methods Mol Biol; 2017; 1558():111-124. PubMed ID: 28150235
[TBL] [Abstract][Full Text] [Related]
54. Drug-Target Interaction Prediction with Graph Regularized Matrix Factorization.
Ezzat A; Zhao P; Wu M; Li XL; Kwoh CK
IEEE/ACM Trans Comput Biol Bioinform; 2017; 14(3):646-656. PubMed ID: 26890921
[TBL] [Abstract][Full Text] [Related]
55. A review on computer-aided chemogenomics and drug repositioning for rational COVID-19 drug discovery.
Maghsoudi S; Taghavi Shahraki B; Rameh F; Nazarabi M; Fatahi Y; Akhavan O; Rabiee M; Mostafavi E; Lima EC; Saeb MR; Rabiee N
Chem Biol Drug Des; 2022 Nov; 100(5):699-721. PubMed ID: 36002440
[TBL] [Abstract][Full Text] [Related]
56. Chemogenomics: drug discovery's panacea?
Jacoby E
Mol Biosyst; 2006 May; 2(5):218-20. PubMed ID: 16880939
[TBL] [Abstract][Full Text] [Related]
57. Updates on drug-target network; facilitating polypharmacology and data integration by growth of DrugBank database.
Barneh F; Jafari M; Mirzaie M
Brief Bioinform; 2016 Nov; 17(6):1070-1080. PubMed ID: 26490381
[TBL] [Abstract][Full Text] [Related]
58. Overview on the current status of virtual high-throughput screening and combinatorial chemistry approaches in multi-target anticancer drug discovery; Part I.
Geromichalos GD; Alifieris CE; Geromichalou EG; Trafalis DT
J BUON; 2016; 21(4):764-779. PubMed ID: 27685895
[TBL] [Abstract][Full Text] [Related]
59. Predicting drug-target interaction for new drugs using enhanced similarity measures and super-target clustering.
Shi JY; Yiu SM; Li Y; Leung HC; Chin FY
Methods; 2015 Jul; 83():98-104. PubMed ID: 25957673
[TBL] [Abstract][Full Text] [Related]
60. Inferring Interactions between Novel Drugs and Novel Targets via Instance-Neighborhood-Based Models.
Shi JY; Li JX; Chen BL; Zhang Y
Curr Protein Pept Sci; 2018; 19(5):488-497. PubMed ID: 27829347
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
